Lonza Group AG Price, Chart & Factor Exposure
Free Data & Analytics AccessNext earnings: Wed, Jan 27, 2027, after the market closes · estimates and history
Lonza Group AG Forecast
Lonza Group AG short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 22.0% a year, a typical one-standard-deviation range is 620.92–660.68 over a week, 600.06–681.54 over a month and 499.68–781.92 over a year. (Signals as of 1 Nov 2026.)
Lonza Group AG Price Chart
Lonza Group AG Factors
YoY −15.6%
YoY +17.9%
YoY +26.8%
YoY +10.1%
YoY +16.1%
YoY −62.6%
YoY +18.4%
YoY +19.6%
YoY +19.4%
YoY −0.7%
YoY −7.0%
YoY +14.2%
YoY +39.1%
YoY −16.1%
YoY −4.1%
YoY +75.0%
YoY +14.8%
Lonza Group AG fundamentals: income statement, balance sheet & cash flow
Lonza Group AG reported revenue of 6.53bn CHF and net income of 949.0m CHF in FY2025, the year ended 31 December 2025 — revenue up 19.2% and net income up 49.2% on the prior year. Free cash flow was -204.0m CHF. These figures are as reported in the filings, not restated: 22 fiscal years and 74 quarters of history, back to December 2004.
| CHF millions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 6,531.0 | 5,480.0 | 6,717.0 | 6,223.0 | 5,409.0 |
| Cost of revenue | 4,222.0 | 3,508.0 | 4,901.0 | 3,923.0 | 3,440.0 |
| Gross profit | 2,309.0 | 1,972.0 | 1,816.0 | 2,300.0 | 1,969.0 |
| Research & development | 112.0 | 102.0 | 105.0 | 95.0 | 90.0 |
| Operating income | 1,239.0 | 1,092.0 | 854.0 | 1,349.0 | 819.0 |
| EBITDA | 1,886.0 | 1,739.0 | 1,475.0 | 1,945.0 | 1,341.0 |
| Interest expense | 168.0 | 145.0 | 108.0 | 73.0 | 72.0 |
| Pre-tax income | 1,101.0 | 708.0 | 790.0 | 1,448.0 | 760.0 |
| Income tax | 192.0 | 106.0 | 135.0 | 230.0 | 83.0 |
| Net income | 949.0 | 636.0 | 654.0 | 1,215.0 | 2,944.0 |
Download Lonza Group AG fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.LONN.SW&statement=all&freq=a&format=csv&years=10
Figures in CHF, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.
Research on Lonza Group AG
Explore MacroFinance macro & markets research and analysis.
Lonza Group AG Trading Strategies
9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Lonza Group AG; 1 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in VGK | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Adaptive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Defensive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Protective Asset Allocation - CPR | Moderate | Monthly | Premium · upgrade to view | |||
| Financial Mentor's Optimum3 | Moderate | Monthly | Premium · upgrade to view | |||
| Wouter Keller's Bold Asset Allocation - Balanced | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Protective Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Vigilant Asset Allocation - Balanced | Moderate | Monthly | Premium · upgrade to view | |||
| Ilya Kipnis' Defensive Adaptive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keuning and Keller's Generalized Protective Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Lonza Group AG’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Lonza Group AG (Switzerland)
Lonza Group AG is a listed security in Switzerland. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
Frequently asked questions
What is Lonza Group AG?
What is the latest Lonza Group AG price?
Is Lonza Group AG in an uptrend?
How volatile is Lonza Group AG?
What factors affect Lonza Group AG?
Which trading strategies trade Lonza Group AG?
How are Lonza Group AG returns analysed?
Where can I download free Lonza Group AG historical data?
Free Lonza Group AG historical data (last 10 years)
Browse or instantly download the last 10 years of Lonza Group AG daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.LONN.SW&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 651.2 |
| 2026-11-19 | 667 |
| 2026-11-18 | 666.6 |
| 2026-11-17 | 663 |
| 2026-11-16 | 670.2 |
| 2026-11-13 | 666 |
| 2026-11-12 | 666 |
| 2026-11-11 | 663.6 |
| 2026-11-10 | 661 |
| 2026-11-09 | 659.4 |
About this stock
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.